Lithium Controlled-Release and Extended-Release Tablets and Oxymetazoline ophthalmic
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Oxymetazoline ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: oxymetazoline ophthalmic
Brand name: Visine LR, Visine Long Lasting, Ocuclear
Synonyms: Oxymetazoline (Ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Oxymetazoline topical
- Lithium Controlled-Release and Extended-Release Tablets-Oxymetazoline Topical application
- Lithium Controlled-Release and Extended-Release Tablets-Oxymetholone
- Lithium Controlled-Release and Extended-Release Tablets-Oxymorphone
- Lithium Controlled-Release and Extended-Release Tablets-Oxymorphone Extended-Release Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Oxymorphone Hydrochloride
- Oxymetazoline ophthalmic-Lithium ER
- Oxymetazoline ophthalmic-Lithium Oral Solution
- Oxymetazoline ophthalmic-Lithium Salts
- Oxymetazoline ophthalmic-Lithium Syrup and Oral Solution
- Oxymetazoline ophthalmic-Lithobid
- Oxymetazoline ophthalmic-Lithostat